1. Mamidi, Murali K, Huang, Jifeng, Honjo, Kazuhito, Leu, Chuen-Miin, Davis, Randall S. 2023. FCRL1 immunoregulation in B cell development and malignancy. In Frontiers in immunology, 14, 1251127. doi:10.3389/fimmu.2023.1251127. https://pubmed.ncbi.nlm.nih.gov/37822931/
2. Khanzadeh, Ali, Habibagahi, Zahra, Hosseini, Ahmad, Amirghofran, Zahra. 2016. Investigation of the human FCRL1, 2, and 4 gene expressions in patients with rheumatoid arthritis. In Rheumatology international, 36, 1149-56. doi:10.1007/s00296-016-3495-2. https://pubmed.ncbi.nlm.nih.gov/27193470/
3. Jamshidian Tehrani, Narges, Amirghofran, Zahra, Shamsaeefar, Ali Reza, Karachi, Aida, Karimi, Mohammad Hossein. 2020. Fc Receptor-Like Gene Expression in Renal Transplantation Patients. In Galen medical journal, 9, e1730. doi:10.31661/gmj.v9i0.1730. https://pubmed.ncbi.nlm.nih.gov/34466580/
4. Davis, Randall S. 2020. Roles for the FCRL6 Immunoreceptor in Tumor Immunology. In Frontiers in immunology, 11, 575175. doi:10.3389/fimmu.2020.575175. https://pubmed.ncbi.nlm.nih.gov/33162991/
5. Zhao, Xingwang, Xie, Hengyi, Zhao, Meng, Kim, Tae Jin, Liu, Wanli. 2019. Fc receptor-like 1 intrinsically recruits c-Abl to enhance B cell activation and function. In Science advances, 5, eaaw0315. doi:10.1126/sciadv.aaw0315. https://pubmed.ncbi.nlm.nih.gov/31328160/
6. Yousefi, Zahra, Sharifzadeh, Sedigheh, Yar-Ahmadi, Vali, Andalib, Alireza, Eskandari, Nahid. 2019. Fc Receptor-Like 1 as a Promising Target for Immunotherapeutic Interventions of B-Cell-Related Disorders. In Biomarker insights, 14, 1177271919882351. doi:10.1177/1177271919882351. https://pubmed.ncbi.nlm.nih.gov/31798301/
7. Gil-Varea, Elia, Spataro, Nino, Villar, Luisa María, Montalban, Xavier, Comabella, Manuel. 2020. Targeted resequencing reveals rare variants enrichment in multiple sclerosis susceptibility genes. In Human mutation, 41, 1308-1320. doi:10.1002/humu.24016. https://pubmed.ncbi.nlm.nih.gov/32196808/
8. Al-Amodi, Hiba S, Bedair, Hanan M, Gohar, Suzy, Efat, Alaa, Abdelsattar, Shimaa. 2025. FCRL1 and BAFF mRNA Expression as Novel Diagnostic and Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma: Expression Signatures Predict R-CHOP Therapy Response and Survival. In International journal of molecular sciences, 26, . doi:10.3390/ijms26031269. https://pubmed.ncbi.nlm.nih.gov/39941037/
智鼠故事 
